Systemic, Inhaled Glucocorticoid Use Linked to Changes in the Brain
To investigate the association between glucocorticoids and and brain structure changes, researchers used data from the UK Biobank.
Neurology
Behavioral Therapy Tied to Reduced Tic Severity in Youth With Tourette Syndrome
Researchers sought to determine the long-term durability of CBIT in youth with Tourette syndrome and persistent motor or vocal tic disorders.
![HYQVIA (immune globulin [human] 10% with recombinant human hyaluronidase) by Baxter and Halozyme](https://www.medicalbag.com/wp-content/uploads/sites/19/2022/07/hyqviaarticle_656631.png)
Hyqvia Reduces Relapse in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Trial
The ADVANCE-1 trial included adults with a confirmed diagnosis of CIDP who had remained on a stable dosing regimen of IVIG therapy for at least 3 months prior to screening.
Clinical Challenge: Bilateral Blurry Vision
A man in his late 40s comes to the emergency department with a complaint of blurry vision that lasted for approximately 20 minutes before returning to normal. The loss of focused vision affected both eyes. Can you make the diagnosis?
Atypical Posterior Stroke: Diagnosing Cause of Vertigo in Primary Care
A patient presenting with dizziness undergoes a thorough workup to identify a peripheral or central cause of vertigo.
Generic Version of Cuvposa Now Available
Glycopyrrolate Oral Solution is supplied as 1mg/5mL in a 16oz bottle.
FDA Clears VNS Device for Paroxysmal Hemicrania, Hemicrania Continua
Patients treated with gammaCore experienced clinically meaningful benefits.
Spinal Muscular Atrophy: Early Diagnosis for Proactive Management
Early diagnosis and treatment of SMA can limit disease progression in children and adults, extending life expectancy and improving QOL.
Cullin 3 (CUL3) a Possible Future Therapeutic Target for Autism Spectrum Disorder
The study authors concluded that mice with decreased Cul3 expression had behavioral changes and depleted neural cell migration.
Nurtec ODT Approval Expanded to Include Migraine Prevention
Rimegepant is an oral calcitonin gene-related peptide receptor antagonist.
- Loading...
Loading...
Loading... 
Loading...